Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
KI ›
KIRA PHARMA
Trademark search for:
KIRA PHARMA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-09-09 — Application filed
2020-09-12 — Application filed
2020-10-15 — Application filed
2021-01-11 — Assigned to examiner
2021-01-15 — Final disposition recorded
2021-01-15 — Final disposition recorded
2021-01-15 — Final disposition recorded
2021-05-25 — Office action issued
2021-05-25 — Correspondence received in law office
2021-05-26 — Teas/email correspondence entered
2021-07-06 — Examiners amendment and/or priority action - completed
2021-07-06 — Combined examiner's amendment/priority action automatic entry
2021-07-06 — Examiner's amendment/priority action e-mailed
2021-07-06 — Notification of examiner's amendment/priority action e-mailed
2021-08-26 — Office action issued
2021-08-31 — Assigned to lie
2021-09-01 — Correspondence received in law office
2021-09-01 — Teas/email correspondence entered
2021-09-17 — Approved for pub - principal register
2021-10-06 — Notification of notice of publication e-mailed
2021-10-26 — Published for opposition
2021-10-26 — Official gazette publication confirmation e-mailed
2021-12-21 — Noa e-mailed - sou required from applicant
2022-06-21 — Sou teas extension received
2022-06-21 — Sou extension 1 filed
2022-06-21 — Sou extension 1 granted
2022-06-23 — Notice of approval of extension request e-mailed
2022-12-16 — Sou teas extension received
2022-12-16 — Sou extension 2 filed
2022-12-16 — Sou extension 2 granted
2022-12-20 — Notice of approval of extension request e-mailed
2023-06-16 — Sou teas extension received
2023-06-16 — Sou extension 3 filed
2023-06-16 — Sou extension 3 granted
2023-06-20 — Notice of approval of extension request e-mailed
2023-12-21 — Sou extension 4 granted
2023-12-21 — Sou teas extension received
2023-12-21 — Sou extension 4 filed
2023-12-23 — Notice of approval of extension request e-mailed
2023-12-28 — Teas revoke/app/change addr of atty/dom rep received
2023-12-28 — Attorney/dom.rep.revoked and/or appointed
2023-12-28 — Teas withdrawal of attorney received-firm retains
2023-12-28 — Teas change of correspondence received
2024-06-17 — Sou teas extension received
2024-06-17 — Notice of approval of extension request e-mailed
2024-06-17 — Sou extension 5 filed
2024-06-17 — Sou extension 5 granted
2024-12-04 — Use amendment filed
2024-12-04 — Teas statement of use received
2025-02-18 — Case assigned to intent to use paralegal
2025-02-18 — Statement of use processing complete
2025-03-25 — Final disposition recorded
2025-03-25 — Final disposition recorded
2025-03-25 — Final disposition recorded
2025-07-16 — Application abandoned
2025-07-16 — Application abandoned
2025-07-16 — Final status recorded
Owner Information
Kira Pharmaceuticals (US) LLC
Cambridge , MA
Kira Pharmaceuticals (US) LLC
Cambridge , MA
Correspondent
Muzamil Huq MORRISON & FOERSTER LLP 425 MARKET STREET SAN FRANCISCO, CA 94105 United States
Filing Details
Filing Date:
2020-09-09
Status Date:
2025-07-16
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.